![(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE CAS 171482-05-6](/images/load_icon.gif){kind=icon}
![(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE CAS 171482-05-6](/photo/pl205851106-2r_3s_2_1r_1_3_5_bis_trifluoromethyl_phenyl_ethoxy_3_4_fluorophenyl_morpholine_hydrochloride_cas_171482_05_6.jpg)
Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 171482-05-6
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,T/T,D/P,Western Union,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
White To Off-white Solid |
CAS NO:: |
171482-05-6 |
Molecular Formula:: |
C20H19ClF7NO2 |
Molecular Weight:: |
473.81200 |
EINECS NO:: |
691-262-0 |
MDL NO:: |
MFCD13183776 |
Appearance:: |
White To Off-white Solid |
CAS NO:: |
171482-05-6 |
Molecular Formula:: |
C20H19ClF7NO2 |
Molecular Weight:: |
473.81200 |
EINECS NO:: |
691-262-0 |
MDL NO:: |
MFCD13183776 |
Product Description:
Product Name:
(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE CAS NO: 171482-05-6
Synonyms:
(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride (1:1);
Aprepitant HCl;
Aprepitant M2 Metabolite (1R, 2R, 3S);
Chemical & Physical Properties:
Appearance: White to off-white solid
Assay :≥99.00%
Boiling Point: 387.9℃ at 760 mmHg
Flash Point: 188.4℃
5-[[(2R, 3S) -2-[(1R) -1-[3, 5-bis (trifluoromethyl) phenyl] ethoxy]-3- (4-fluorophenyl) -4-morphoryl] methyl]-1, 2-dihydro-3H-1, 2, chemicalbook4-triazol-3-ketone It is an antiemetic drug developed by Merck in the United States for the prevention of acute and delayed vomiting during chemotherapy. Clinical studies have shown that adjuvant administration of aprepitant can significantly control chemotherapy-induced nausea and vomiting (CINV) symptoms in the use of moderate and highly emetic chemotherapy drugs.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
